Back to Search
Start Over
Design of non-aggregating variants of Aβ peptide
- Source :
- Biochemical and biophysical research communications. 453(3)
- Publication Year :
- 2014
-
Abstract
- Self association of the amyloid-β (Aβ42) peptide into oligomers, high molecular weight forms, fibrils and ultimately neuritic plaques, has been correlated with progressive cognitive decline in Alzheimer’s disease. Thus, insights into the drivers of the aggregation pathway have the capacity to significantly contribute to our understanding of disease mechanism. Functional assays and a three-dimensional crystal structure of the P3 amyloidogenic region 18–41 of Aβ were used to identify residues important in self-association and to design novel non-aggregating variants of the peptide. Biophysical studies (gel filtration, SDS–PAGE, dynamic light scattering, thioflavin T assay, and electron microscopy) demonstrate that in contrast to wild type Aβ these targeted mutations lose the ability to self-associate. Loss of aggregation also correlates with reduced neuronal toxicity. Our results highlight residues and regions of the Aβ peptide important for future targeting agents aimed at the amelioration of Alzheimer’s disease.
- Subjects :
- Amyloid beta
Biophysics
Peptide
Fibril
Biochemistry
PC12 Cells
chemistry.chemical_compound
Animals
Senile plaques
Benzothiazoles
Molecular Biology
chemistry.chemical_classification
Amyloid beta-Peptides
biology
Chemistry
Aβ peptide
Wild type
P3 peptide
Cell Biology
Cell biology
Rats
Thiazoles
Mutation
biology.protein
Microscopy, Electron, Scanning
Thioflavin
Peptides
Subjects
Details
- ISSN :
- 10902104
- Volume :
- 453
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Biochemical and biophysical research communications
- Accession number :
- edsair.doi.dedup.....7b9cc0fd819950d6876853cc6eb246d2